Clinical Trial Update: Ruxolitinib + Allogeneic Stem Cell Transplantation in AML [Phase 2]

View source ↗

Summary

A Phase 2 trial assesses combining ruxolitinib with allogeneic stem cell transplantation for acute myeloid leukemia, including AML in remission. The study is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Acute Myeloid Leukemia in Remission

Drugs mentioned

• Ruxolitinib (ruxolitinib)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Acute Myeloid Leukemia, Acute Myeloid Leukemia in Remission | Phase 2 | Status: ACTIVE_NOT_RECRUITING